CRNX vs NOC · rev $35.9M vs P/E 17, rev $20.76B
Crinetics Pharmaceuticals Inc (CRNX) versus Northrop Grumman Corporation (NOC) — a side-by-side from cached financials, not a winner call.
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Latest reported CRNX revenue for 2026-06-30 was $35.9M. Net income was -$248.7M. CRNX currently screens at market cap $2.76B.
Latest reported NOC revenue for 2026-06-30 was $20.76B. Net income was $1.97B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
CRNX currently screens at market cap $2.76B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Not investment advice. Open the CRNX and NOC stock pages for the full models.
Not investment advice.